Lower prevalence of H63D in AD patients compared to controls (18.0% vs. 29.9%; OR = 0.352, CI = 0.21–0.60; p < 0.05). No difference in prevalence of C282Y between AD patients and controls. This remained insignificant when stratifying by TF C2 presence (p-values not reported). The gene discussed is TF; the disease is Alzheimer disease.